Notably, CCA and PDAC exhibit overlapping miRNA-regulated molecular pathways, such as KRAS, PI3K/AKT, TGF-β, and Notch signaling, highlighting shared oncogenic mechanisms and potential convergent therapeutic vulnerabilities. This evidence concerns the gene AKT1 and cholangiocarcinoma.